FIELD: medicine.
SUBSTANCE: invention relates to novel derivatives of vitamin B6 of general formula (I) with high antibacterial activity.
,
where at R1=R4=N+(CH3)2C8H17, R2+R3=-C(CH3)2O-, R5=H, n=2, m=0; at R1=R4=N+(CH3)2C12H25, R2+R3=-C(CH3)2O-, R5=H, n=2, m=0; at R1=R4=N+(CH3)2C18H37, R2+R3=-C(CH3)2O-, R5=H, n=2, m=0; at R1=R4=N+(CH3)2C8H17, R2=R5=H, R3=OH, n=2, m=1; at R1=R4=N+(CH3)2C12H25, R2=R5=H, R3=OH, n=2, m=1; at R1=R4=N+(CH3)2C18H37, R2=R5=H, R3=OH, n=2, m=1; at R1=R5=H, R2+R3=-CH(C2H5)O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-CH(C3H7)O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-CH(C4H9)O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-CH(C(CH3)3)O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-CH(C8H17)O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-CH(CH2CH(CH3)C9H19)O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-CH2O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-C(cycle-C4H8)O-, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R5=H, R2+R3=-CH(C3H7)O-, R4=N+(CH3)2C8H17, n=1, m=0; at R1=R5=H, R2+R3=-CH(C3H7)O-, R4=N+(CH3)2C12H25, n=1, m=0; at R1=R5=H, R2+R3=-CH2O-, R4=N+(CH3)2C8H17, n=1, m=0; at R1=R5=H, R2+R3=-CH2O-, R4=N+(CH3)2C12H25, n=1, m=0; at R1=R5=H, R2+R3=-C(CH3)2O-, R4=N+(CH3)2C12H25, n=1, m=0; at R1=R2=R5=H, R3=OH, R4=N+(CH3)2C12H25, n=1, m=1; at R1=R3=R5=H, R2=C(O)CH3, R4=N+(CH3)2C8H17, n=1, m=0; at R1=R3=R5=H, R2=C(O)CH3, R4=N+(CH3)2C12H25, n=1, m=0; at R1=R3=R5=H, R2=C(O)CH3, R4=N+(CH3)2C18H37, n=1, m=0; at R1=R2=R3=R5=H, R4=N+(CH3)2C8H17, n=1, m=1; at R1=R2=R3=R5=H, R4=N+(CH3)2C12H25, n=1, m=1; at R1=R2=R3=R5=H, R4=N+(CH3)2C18H37, n=1, m=1; at R1=N+(CH3)2C8H17, R2+R3=-C(CH3)2O-, R4+R5=-OC(CH3)2OCH2-, n=1, m=0; at R1=N+(CH3)2C18H37, R2+R3=-C(CH3)2O-, R4+R5=-OC(CH3)2OCH2-, n=1, m=0; at R1=N+(CH3)2C8H17, R2+R3=-C(CH3)2O-, R4=OH, R5=CH2OH, n=1, m=1; at R1=N+(CH3)2C18H37, R2=H, R3=R4=OH, R5=CH2OH, n=1, m=1.
EFFECT: invention can be used in medicine and veterinary science.
1 cl, 2 tbl, 30 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBACTERIAL AGENTS BASED ON QUATERNARY AMMONIUM SALTS | 2014 |
|
RU2561281C1 |
QUATERNARY AMMONIUM COMPOUNDS BASED ON PENTAERYTHRITOL AND PYRIDOXINE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY | 2023 |
|
RU2811203C1 |
QUATERNARY AMMONIUM COMPOUNDS BASED ON 3-HYDROXYPYRIDINE WITH ANTIBACTERIAL ACTIVITY | 2021 |
|
RU2778507C1 |
QUATERNARY AMMONIUM COMPOUNDS BASED ON DERIVATIVES OF PYRIDOXINE AND FATTY CARBOXYLIC ACIDS WITH ANTIBACTERIAL ACTIVITY | 2022 |
|
RU2795265C1 |
BIS-AMMONIUM COMPOUNDS BASED ON PYRIDOXINE, HAVING ANTIBACTERIAL AND ANTIMYCOTIC PROPERTIES | 2020 |
|
RU2731999C1 |
PYRIDOXIN AND ACETONE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2017 |
|
RU2639879C1 |
PHOSPHONIUM SALTS ON BASIS OF PYRIDOXINE DERIVATIVES | 2011 |
|
RU2466728C1 |
FLUOROQUINOLONES BASED ON 4-DEOXYPYRIDOXINE | 2016 |
|
RU2634122C1 |
2-(CHROMENO[4,3-D]PYRIMIDIN-5-YL)ACETIC ACID DERIVATIVES AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2716597C1 |
FLUOROQUINOLONE COMPOUNDS BASED ON PYRIDOXINE DERIVATIVES, HAVING ANTIBACTERIAL PROPERTIES | 2019 |
|
RU2713932C1 |
Authors
Dates
2017-01-10—Published
2015-12-02—Filed